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Congenital deficiency of the proprotein convertase subtilisine/kexin type 1 gene (PCSK1), which encodes
proprotein convertase 1/3, causes a severe multihormonal disorder marked by early-onset obesity. The single
nucleotide polymorphisms (SNPs) rs6232 and rs6234–rs6235 in PCSK1 have been associated with obesity. How-
ever, case-control studies carried out in populations of different ethnicities have only partly replicated this associ-
ation. Moreover, these SNPs have only weakly been associated with bodymass index (weight (kg)/height (m)2) at a
genome-wide level of significance. To investigate this discrepancy, we conducted a systematic search for studies
published before December 2013 and extracted relevant data. Pooled estimates were calculated for overall and
subgroup analyses. This meta-analysis confirmed the association of PCSK1 SNPs with obesity and provides the
first evidence that the association between PCSK1 rs6232 and obesity is stronger for childhood obesity than for
adult obesity. Moreover, we identified weak associations with body mass index and significantly stronger associa-
tions with waist circumference for rs6234–rs6235. No difference was found in the association with different obesity
grades, and no association ofPCSK1 rs6234–rs6235 with obesity was identified in Asian populations. This system-
atic Human Genome Epidemiology (HuGE) review showed convincingly that the SNPs rs6232, rs6234, and rs6235
in PCSK1 are associated with obesity in Caucasians.
body mass index; genetic association studies; genetic epidemiology; genome, human; obesity; PCSK1; proprotein
convertase 1/3; waist circumference
Abbreviations: BMI, body mass index; CI, confidence interval; FTO, fat mass and obesity-associated gene; LEP, leptin gene;
MeSH, Medical Subject Headings; OR, odds ratio; PCSK1, proprotein convertase subtilisine/kexin type 1 gene; PC1/3, proprotein
convertase 1/3; SNP, single nucleotide polymorphism; STREGA, Strengthening the Reporting of Genetic Association Studies;WC,
waist circumference; WHO, World Health Organization.
Editor’s note: This article also appears on the website of
the Human Genome Epidemiology Network (http://www.cdc.
gov/genomics/hugenet/default.htm).
According to the World Health Organization (WHO),
there is currently a global epidemic of obesity (1). This in-
crease in obesity prevalence since 1980 can be attributed to a
general change in lifestyle—for example, increased consump-
tion of calorie-dense foods and reduced physical activity. In
addition to this change in lifestyle, which accompanies the
process of industrialization, obesity has a strong hereditary
component. The proprotein convertase subtilisin/kexin type
1 gene (PCSK1) and the leptin gene (LEP) were the first genes
to be implicated in severe early-onset obesity (2, 3).
PCSK1 encodes proprotein convertase 1/3 (PC1/3), which
is responsible for the activation of several hormones and
neuropeptides important for thermogenesis and feeding be-
havior, supporting a role in the pathogenesis of obesity. Be-
sides the implication in feeding behavior and thermogenesis,
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PCSK1 has also been implicated in glucose homeostasis,
proinsulin disorders, fat oxidation, and postabsorptive rest-
ing energy expenditure (4–10). In 1997, the case of a patient
with congenital PCSK1 deficiency and severe obesity was re-
ported (2). Since then, several other patients with congenital
PCSK1 deficiency have been identified. The patients with
congenital PCSK1 deficiency were all born full-term with a
normal birth weight (2, 11–16). Shortly after birth, the infants
began to experience metabolic acidosis, dehydration, and di-
arrhea. The majority of the patients survived only with total
parenteral nutrition. In midchildhood (around age 6 years),
the dependency on parenteral feeding decreased, diarrhea
diminished, and patients showed hyperphagia, polydipsia,
polyuria, and rapid weight gain (13). This multihormone dys-
function further included hypocortisolism, growth hormone
deficiency, postprandial hypoglycemia, hypogonadism, and
reduced thyroid function. In different animal species, func-
tional single nucleotide polymorphisms (SNPs) in PCSK1
orthologs have been found to be associated with fat deposi-
tion and growth traits (17–21).
In 2008, Benzinou et al. (22) reported on the association of
3SNPs—rs6232, rs6234, and rs6235—with obesity, ofwhich
rs6234 and rs6235 were shown to be in strong linkage dis-
equilibrium. Odds ratios were reported as 1.34 and 1.22 for
rs6232 and the SNP pair rs6234–6235, respectively. Since
then, other case-control studies have been conducted in co-
horts of European, Mexican, North American, and Asian de-
scent (23–26). The initial findings by Benzinou et al. (22)
were only partially replicated. With the start of the genome-
wide association study era, multiple studies were conducted
in European, Asian, and African populations (21, 27–30).
Several SNPs were identified as contributing to body mass
index (BMI; weight (kg)/height (m)2), butPCSK1 SNPswere
only marginally associated with BMI (31, 32).
In order to obtain insight into this discrepancy, it is im-
portant to look for variables in study design that might have
influenced the association between PCSK1 variants and obe-
sity. In this study, we assessed the association of the PCSK1
SNPs rs6232 and rs6234–rs6235 with obesity and with quan-
titative traits, such as BMI and waist circumference (WC).
To address this question, we undertook a systematic Human
Genome Epidemiology (HuGE) review and meta-analysis of
the present literature. Using meta-regression and subgroup
analysis, we aimed to identify populations at risk, in which
carriers of the minor alleles have increased risk of obesity.
METHODS
Search strategy
We performed a sensitive search in order to find both pub-
lished and unpublished records. The electronic databases Med-
line (US National Library of Medicine, Bethesda, Maryland),
Web of Science (Thomson Reuters Corporation, New York,
New York), and Embase (Excerpta Medica, Elsevier B.V.,
Amsterdam, the Netherlands) were searchedwith the following
query, which combines a Medical Subject Headings (MeSH)
term with free text: “prohormone convertase 1” OR “PCSK1”
OR “PC1/3” OR “proprotein convertase 1” OR “Proprotein
Convertase 1”[MeSH]. The final search was conducted on
November 27, 2013. Additionally, using Web of Science, we
screened for articles which referred to or shared references with
the paper byBenzinou et al. (22). Full articles, congress proceed-
ings, and reference lists were checked for novel information.
Inclusion criteria
The following requirements were set for the inclusion of
studies: 1) The study had a case-control design for obese ver-
sus lean individuals or reports on quantitative traits of BMI or
WC; 2) the study was not a family-based association study;
3) obesity was defined according to the WHO cutoffs for
BMI (33, 34); 4) the study reported on rs6232, rs6234, or
rs6235 in humans; 5) complete information was available
or was personally provided by the study investigators; and
6) for different studies reporting on the same cohorts, only
the most complete and largest cohorts were used.
Quality appraisal
The quality of each study was critically assessed using the
Strengthening the Reporting of Genetic Association Studies
(STREGA) statement (35). The following aspects of each
study were appraised: genotyping procedures and quality
control, description of the study cohort, case-control match-
ing, adjustment forcovariates, adjustment formultiple compa-
risons, reporting of statistical methods, reporting of genotype
frequency per case/control group, reporting of cohort charac-
teristics for cases and controls separately, and reporting of de-
parture from Hardy-Weinberg equilibrium.
Data collection and extraction
The following data were extracted in a standardized man-
ner by 2 of the authors (P.S. and K.T.) independently: first
author and publication year, included case/control cohorts,
effect size per cohort, number of participants per cohort, ge-
netic model used, ethnicity, average age of the case cohort or
calculated average age, and average BMI or obesity grade ac-
cording toWHO definitions (33, 34). For the quantitative traits
BMI and WC, β coefficients and measures of error (standard
error or 95% confidence interval) were extracted. Ethnicity
was categorized as Caucasian, African-American, Asian, or
Hispanic. On the basis of nationality, Mexicans were catego-
rized as Hispanic; Taiwanese and Chinese persons were cat-
egorized as Asian; and North American whites and European
populations were categorized as Caucasian. African Ameri-
cans were categorized as such. When average BMI was
available, it was categorized into 3 obesity grades (grade I:
30–<35; grade II: 35–<40; grade III: ≥40) according to the
WHO definitions (33). For Asians, there is no clear consen-
sus on appropriate obesity cutoff values because of large eth-
nic heterogeneity. Therefore, both BMI ≥27 and BMI ≥28
were accepted as cutoffs. When information on average age
was not available, this was calculated from the supplemen-
tary data. Cohorts were considered childhood cohorts when
the average agewas less than 18 years. Both the 95th and 97th
percentiles were accepted as obesity cutoffs for childhood
cohorts.












The selected studies were partitioned into their constituent
cohorts to allow for subgroup analysis and meta-regression.
The data were analyzed for rs6232 and rs6234–rs6235 sepa-
rately. Data on rs6234 or rs6235 were combined, because
these SNPs are reported to be in very high linkage disequi-
librium in all investigated ethnic groups (Caucasians: r2 >
0.96 (22); African Americans and Hispanics: r2 > 0.76 (23);
Chinese Han population: r2 > 0.98 (36)).
Considering the heterogeneity in the study populations and
study methods, we used the restricted maximum likelihood
random-effects model to calculate summary effects for the
association, subgroup, and regression analyses. Recently it
has been shown that the restricted maximum likelihood
random-effects model performs better than the more popular
DerSimonian and Laird model (37). The heterogeneity of the
studies was investigated using the Q statistic (Q difference,
I2), where I2 values between 25% and 50% were considered
to indicate moderate heterogeneity and values higher than
50% were considered to indicate high heterogeneity (38).
When more than 10 cohorts were included in 1 analysis,
we performed meta-regression using the log odds ratio as
the dependent variable and average age as the independent
variable. Regression was tested using z statistics (omnibus
test for intercept and coefficient), and a bubble plot was gen-
erated. In addition, subgroup analysis was performed when
the subgroup contained at least 4 cohorts. Subgroup analyses
were performed for ethnicity, obesity grade, and adult obesity
versus childhood obesity. Differences between subgroups
were tested using the Q statistic for heterogeneity (39). Pub-
lication bias was investigated with Begg’s funnel plot, using
cohort-specific effect sizes for the association, and asymme-
try was assessed formally using Egger’s test and the rank cor-
relation test (40).
We conducted sensitivity analyses by excluding the ap-
praised study that had the lowest quality and that did not
report on Hardy-Weinberg equilibrium for PCSK1 variants.
A sensitivity analysis could also include studies that were
judged to cause abnormal heterogeneity. Statistical analyses
were performed with OpenMeta[Analyst] software (Center
for Evidence-based Medicine, Brown University School of
Public Health, Providence, Rhode Island) (41) and R 3.02 soft-
ware (R Foundation for Statistical Computing, Vienna, Austria)
(42) using the metafor package (versions 1.9 and 2) (43). Odds
ratios and 95% confidence intervals were calculated.
Assessment of cumulative evidence
The Venice criteria for measuring the credibility of cumu-
lative evidence were applied to assess the strength of the ev-
idence of genetic association (44). Results from the pooled
analyses were rated for amount of evidence, extent of replica-
tion, and protection from bias. For each category, one of
3 grades was given: “A,” strong; “B,” moderate; or “C,”
weak. Epidemiologic evidence was considered strong when
all 3 grades were “A,” moderate when grades included at
least 1 “B” (but no “C”), and weak if any grade was “C.”
In practice, we rated the amount of evidence based upon the
value of the product nminor = (minor allele frequency × no. of
cases). If nminor > 1,000, the evidence was rated A; if nminor >
100, the evidence was rated B; and if nminor < 100, the evi-
dence was rated C. I2 values served as an indication of repli-
cation. I2 values close to 25%were considered to indicate low
heterogeneity; values around 50% were considered to indi-
cate moderate heterogeneity; and values around 75% were
considered to indicate high heterogeneity. Ratings were
given accordingly. Protection from bias was rated, taking
into account the results of the sensitivity analyses and the
quality appraisal process.
RESULTS
For the systematic search, we searched common electronic
databases for references published before November 27,
2013, using a broad query, and reference lists were checked
for unique citations (Figure 1). The sensitive search yielded
Records Found in Databases
674 in Embase
531 in Medline
222 in Web of Science
58 Unique Records After
Screening for PCSK1 in
Humans
52 Unique Studies
21 Studies About the PCSK1
SNPs in Humans
20 Studies Investigating PCSK1
SNPs rs6232 and rs6234–
rs6235 in Relation to Obesity
15 Reported on Obesity Risk
11 Reported on Association
With BMI
  5 Reported on Association 
With Waist Circumference






31 Studies Not Reporting on
PCSK1 SNPs Excluded
1 Study Not Reporting on
BMI, Obesity Risk, or Waist
Circumference Excluded
Figure 1. Search strategy used to select articles published before
December 2013 for a review and meta-analysis of associations be-
tween the proprotein convertase subtilisin/kexin type 1 gene (PCSK1)
single nucleotide polymorphisms (SNPs) rs6232 and rs6234–rs6235
and obesity, body mass index (BMI), and waist circumference. In the
first stage, search results were screened for records about PCSK1 in
humans. In the second stage, duplicate studies were removed. Studies
not reporting on the SNPs rs6232, rs6234, and rs6235 were removed.
Finally, 20 studies were assessed for eligibility, and 19 were included in
the analyses. The selection of studies was carried out by 2 independent
reviewers (P.S. and K.T.), and disagreements were resolved through
discussion.











674 records in Embase, 531 records in Medline, and 222 rec-
ords in Web of Science. Reference lists contained infor-
mation that allowed us to retrieve another 109 references.
Abstracts were screened for relevancy, and duplicate studies
were excluded; this yielded 52 studies about PCSK1 in hu-
mans. Full texts were assessed, and studies that did not report
on the PCSK1 SNPs were excluded. Finally, 21 unique stud-
ies were identified, of which 1 was excluded because it did
not report on the SNPs within the context of obesity, BMI,
or WC. The extensive literature search yielded 20 studies
which were eligible for inclusion (Table 1). Fifteen studies
reported on obesity risk, 11 studies reported on associations
with BMI, and 5 studies reported on associations with WC.
The studies by Meyre et al. (31), Körner et al. (70), and
Benzinou et al. (22) and the studies by Berndt et al. (32) and
Kilpeläinen et al. (26) were found to contain overlapping
cohorts regarding the association with obesity risk. The
smaller cohorts were excluded from these studies (Table 2).
For the Northern Sweden Health and Disease Study cohort
(Renström et al. (65)), novel data were acquired from inves-
tigators in the larger Gene × Lifestyle Interactions and Com-
plex Traits Involved in Elevated Disease Risk (GLACIER)
Study (45). For the analysis of obesity risk, only part of
this cohort could be used because of overlap with data from
the study by Berndt et al. (32). The included studies and their
constituent cohorts are listed in Tables 3 and 4.
The quality of each study was appraised using the criteria
of the STREGA statement (Table 5) (35). In 4 studies, the in-
vestigators did not mention whether duplicate samples were
analyzed as a control for genotyping, and Dušátková et al.
(46) did not report on the genotyping procedures at all.
Every study tested whether genotypes deviated from Hardy-
Weinberg equilibrium, except that by Xi et al. (30). Kilpeläinen
et al. (26), Renström et al. (65), Heni et al. (5), and Hester
et al. (67) did not report participants’ characteristics by geno-
type. In 7 studies, 5 of which were population-based, inves-
tigators did not report cohort characteristics for cases and
controls separately. The 2 remaining studies contributed only
to quantitative trait analyses, not to meta-analyses of obesity
risk. All studies adjusted P values for the covariates sex and
age, while some adjusted for additional covariates. Some
studies neither adjusted for multiple comparisons nor re-
ported genotypes per case/control group (Table 5). Overall,
Dušátková et al. (46) scored the lowest on the quality ap-
praisal criteria, and Xi et al. (30) did not report on Hardy-
Weinberg equilibrium. Consequently, both studies were
included in a sensitivity analysis (seeWebTable 1, available at
http://aje.oxfordjournals.org/). It is possible that investigators
Table 1. Characteristics of Studies Published Before December 2013 That Were Eligible for Inclusion in a Review and Meta-Analysis of
Associations Between the PCSK1 Single Nucleotide Polymorphisms rs6232 and rs6234–rs6235 and Obesity, Body Mass Index, and Waist
Circumference
First Author,
Year (Reference No.) No. of Cases No. of Controls Ethnicity Population
Factors Addressed in the Study
Obesity Risk BMIa WC
Benzinou, 2008 (22) 6,029 6,863 Caucasian Childhood/adult Y N N
Kilpeläinen, 2009 (26) 3,570 17,313 Caucasian Adult Y Y Y
Renström, 2009 (65) 3,885b Caucasian Adult Y Y N
Meyre, 2009 (31) 3,447 3,827 Caucasian Childhood/adult Y Y N
Sandholt, 2010 (10) 2,805 1,080 Caucasian Adult Y Y N
Qi, 2010 (36) 471 1,489 Asian Adult Y N N
Heni, 2010 (5) 1,498 Caucasian Adult N Y Y
Den Hoed, 2010 (66) 28,080 Caucasian Childhood/adult NP NP NP
Gjesing, 2011 (9) 6,164 Caucasian Adult N Y Y
Strawbridge, 2011 (4) 123,260 Caucasian Adult N Y N
Hester, 2012 (67) 4,992 African-American Adult N Y N
Li, 2012 (68) 49 1,051 Asian Adult Y Y Y
Rouskas, 2012 (25) 510 469 Caucasian Adult Y N N
Villalobos-Comparán, 2012 (24) 1,018 1,354 Hispanic Childhood/adult Y N N
Berndt, 2013 (32) 74,549 269,762 Caucasian Adult Y N N
Choquet, 2013 (23) 2,650 2,487 Multiethnic Adult Y Y N
Dušátková, 2013 (46) 670 773 Caucasian Childhood Y N N
Hsiao, 2014 (69) 175 499 Asian Adult Y N N
Xi, 2013 (30) 1,230 1,619 Asian Childhood Y Y Y
Körner, 2010 (70) 704 974 Caucasian Childhood Y N N
Abbreviations: BMI, body mass index; N, no; NP, not provided; PCSK1, proprotein convertase subtilisin/kexin type 1 gene; WC, waist
circumference; Y, yes.
a Weight (kg)/height (m)2.
b In some studies, numbers of cases and controls were not reported separately.











in some studies did take these measures into account but did
not report it.
We performed an extensive search for unpublished data
using different electronic databases and reference lists to min-
imize publication bias. In addition, Begg’s funnel plots were
generated for the published associations of both SNPs with
obesity risk (Web Figure 1). For rs6234–rs6235, there was
no indication of plot asymmetry visually or according to
Egger’s test (P = 0.54) or the rank correlation test (P = 0.60).
For rs6232, Egger’s test and the rank correlation test gave
contradicting results (P = 0.004 and P = 0.68) (40, 47). For
the association of rs6232 and rs6234–rs6235 with quantita-
tive traits, there were no indications of publication bias ac-
cording to Egger’s test or the rank correlation test (P > 0.05).
Meta-analyses of the association of PCSK1 SNPs with
obesity risk
The meta-analysis that included all cohorts showed that
both rs6232 and rs6234–rs6235 were significantly associated
with obesity status (odds ratio (OR) = 1.19 (95% confidence
interval (CI): 1.09, 1.29) and OR = 1.09 (95%CI: 1.04, 1.13),
respectively) (Tables 6 and 7). Heterogeneity was consider-
able for both meta-analyses (rs6232: I2 = 50%; rs6234–
rs6235: I2 = 65%) (Tables 6 and 7, Web Figure 2).
Subgroup meta-analysis according to obesity severity
The case-control study design enriches the sample for se-
vere phenotypes, in contrast to population samples. This
could render the case-control design more sensitive to finding
associations (48). We assessed whether the association with-
in our meta-analysis was dependent on obesity severity, using
the classification defined by the WHO (33, 34). In adult co-
horts, the association was tested for the 3 obesity grades (Web
Figure 3, Tables 6 and 7). For this analysis, we excluded the
Mexican adult obesity grade I/II cohort, since it was not clear
how to categorize obesity in this cohort. There was a strong
association of rs6232 with obesity grade I (OR = 1.09, 95%
CI: 1.02, 1.16) but not with grade II (OR = 1.16, 95% CI:
0.91, 1.49) or grade III (OR = 1.21, 95% CI: 0.84, 1.74)
(Table 6). The absence of an association with obesity grade
II could be explained by the limited number of studies and the
low accuracy of the studies. The absence of association in the
most severe obesity grade, grade III, could be explained by
the high level of heterogeneity (I2 = 78%), which was driven
by the negative association in the Swiss cohort of obese
adults (Web Figure 3). Upon closer investigation of this co-
hort, describedbyMeyreet al. (31),wenoted thatof the limited
number of controls (n = 320), no homozygous individuals
were present. Within an additive genetic model, this can
lead to severe bias. Therefore, we performed a sensitivity
analysis, replacing this cohort with the Swiss participant sam-
ple described by Benzinou et al. (22), which was drawn from
the same overall cohort (49). Replacement of the cohort re-
duced the heterogeneity to 32% and induced a significant as-
sociation between class III obesity and rs6232 (OR = 1.33,
95% CI: 1.10, 1.61) (Web Table 2). However, in neither of
the 2 meta-analyses was there a difference in the association
according to obesity grade (P = 0.12 and P = 0.43).
The SNP pair rs6234–rs6235 was significantly associated
with all obesity grade subgroups, but the association did not
vary across subgroups (P = 0.57) (Table 7, Web Figure 3).
The replacement of the Swiss cohort did not induce a signifi-
cant difference in the associations of rs6234–rs6235 with the
different obesity grade subgroups (P = 0.12) (Web Table 2).
Therewas, however, a significant difference between the obe-
sity grade I and obesity grade III subgroups (P = 0.04).
The categorization of the cohorts into obesity grade sub-
groups resulted in a loss of information, and this could have
produced less sensitive analyses. Therefore, in addition to the
previous analyses, we conducted meta-regression analysis for
the mean BMIs of the investigated cohorts. This showed that
with increasing cohort BMI, rs6234–rs6235 was more strongly
associated with obesity (P = 0.02), but this was not true for
rs6232 (P = 0.4).
Subgroup meta-analysis according to average age
Kilpeläinen et al. (26) observed an association with obesity
only in cohort members under 59 years of age. To investigate
whether age has an influence on the association, we divided
the cohorts into childhood obesity cohorts and adult cohorts.
Subgroup analysis showed that the association with obesity
was stronger in childhood cohorts than in adult cohorts for
rs6232 (for childhood cohorts, OR = 1.43, 95% CI: 1.19, 1.73;
Table 2. Characteristics of Overlapping Cohorts in Studies of the
PCSK1Single Nucleotide Polymorphisms rs6232 and rs6234–rs6235
and Obesity Published Before December 2013
First Author, Year (Reference No.) No. ofCases
No. of
Controls
French childhood cohort 1
Benzinou, 2008 (22) 580 1,010
Meyre, 2009 (31) 519 566
Leipzig, Germany, schoolchildren cohort
and Leipzig obese children cohort (70)
Benzinou, 2008 (22) 283 715
Meyre, 2009 (31) 377 731
Körner, 2010 (70) 704 974
Swiss grade III obese cohort (49)
Benzinou, 2008 (22) 542 551
Meyre, 2009 (31) 1,036 320
EPIC-Norfolk cohort (26)
Kilpeläinen, 2009 (26) 3,570 17,313
Berndt, 2013 (32) 4,105a
NSHED–GLACIER cohort (45)
Renström, 2009 (65) 3,885a
GLACIER study 2,401 7,567
Berndt, 2013b (32) 725 2,842
Abbreviations: EPIC, European Prospective Investigation into Can-
cer and Nutrition; GLACIER, Gene × Lifestyle Interactions and Complex
Traits Involved in Elevated Disease Risk; NSHED, Northern Sweden
Health and Disease; PCSK1, proprotein convertase subtilisin/kexin
type 1 gene.
a No information on case and control groups was given.
b Data overlapped only for case-control analyses.











Table 3. Characteristics of Included Studies and Their Constituent Cohorts (Odds Ratio) in a Review and Meta-Analysis of the PCSK1 Single Nucleotide Polymorphisms rs6232 and rs6234–
rs6235 and Obesity Risk, December 2013
First Author,
Year (Reference No.) Cohort
PCSK1 Single Nucleotide Polymorphism
BMIa BMI-for-Agez Score Ethnicity
Mean Age,
yearsrs6232 rs6234–rs6235
OR 95% CI OR 95% CI
Benzinou, 2008 (22) French adults 1.51 1.14, 2.00 1.31 1.15, 1.49 42.8 Caucasian 46.7
Danish adults 1.17 1.01, 1.36 1.12 1.03, 1.22 33.8 Caucasian 57.3
Swiss adults 1.38 0.95, 2.01 1.38 1.15, 1.66 46.8 Caucasian 42.9
French childhood cohort 1 1.67 1.21, 2.31 1.23 1.05, 1.44 4.4 Caucasian 10.6
French childhood cohort 2 1.57 1.07, 2.30 1.50 1.23, 1.83 4.0 Caucasian 11.8
Leipzig obese children 1.56 1.05, 2.32 1.12 0.92, 1.36 2.7 Caucasian 11.5
Renström, 2009 (45, 65) GLACIER grade I 0.98 0.89, 1.08 31.9 Caucasian 55.2
GLACIER grade II 0.97 0.81, 1.17 36.8 Caucasian 53.6
GLACIER grade III 0.85 0.59, 1.23 45.7 Caucasian 54.1
Meyre, 2009 (31) French children 1.22 0.81, 1.82 1.31 1.09, 1.58 4.1 Caucasian 11.5
French adults 1.23 0.67, 2.26 1.10 0.83, 1.46 49.4 Caucasian 41.1
Swiss adults (48) 0.67 0.45, 1.00 0.98 0.80, 1.21 43.7 Caucasian 42.4
Leipzig obese children 1.35 0.93, 1.96 1.06 0.87, 1.30 2.7 Caucasian 11.8
Qi, 2010 (36) SNHAPC 1.02 0.86, 1.21 Grade I Asian 58.6
Sandholt, 2010 (10) Inter99 cohort 1.17 0.95, 1.44 1.12 1.00, 1.25 32.5 Caucasian 46.0
Rouskas, 2012 (25) Greek adults 0.95 0.63, 1.44 0.95 0.63, 1.44 37.6 Caucasian 47.8
Li, 2012 (68) Zhongshan Hospital 1.51 1.00, 2.28 29.3 Asian 55.8
Villalobos-Comparán, 2012 (24) Mexican children 3.78 1.43, 9.99 1.14 0.91, 1.43 2.1 Hispanic 10.3
Mexican adults grade I/II 0.67 0.24, 1.85 1.00 0.79, 1.27 NR Hispanic 41.9
Mexican adults grade III 2.61 1.10, 6.19 1.12 0.84, 1.49 NR Hispanic 41.9
Choquet, 2013 (23) CARDIA I: European Americans 1.71 1.09, 2.68 1.13 0.89, 1.43 36.4 Caucasian 40.6
CARDIA II: African Americans 1.47 1.06, 2.03 37.8 African-American 39.9
MESA I: European Americans 1.12 0.77, 1.63 1.02 0.85, 1.22 34.2 Caucasian 61.1
MESA II: African Americans 0.86 0.66, 1.12 35.2 African-American 61.0
MESA III: Hispanics 0.77 0.34, 1.77 1.08 0.79, 1.47 34.4 Hispanic 60.6
Hsiao, 2014 (69) Taipei University Hospital 1.05 0.83, 1.33 30.1 Asian 39.8
Dušátková, 2013 (46) COPAT Study 1.26 0.87, 1.82 0.94 0.78, 1.13 3.3 Caucasian 15.4
Xi, 2013 (30) BCAMS Study 0.93 0.82, 1.06 2.4 Asian 11.8
Berndt, 2013 (32) Grade I obesity 1.06 1.00, 1.12 1.05 1.02, 1.08 Grade I Caucasian 52.7
Grade II obesity 1.10 1.00, 1.22 1.08 1.04, 1.12 Grade II Caucasian 52.7
Grade III obesity 1.13 0.95, 1.35 1.12 1.04, 1.21 Grade III Caucasian 52.7
Körner (70) Leipzig obese children 1.23 1.03, 1.47 1.44 1.02, 2.04 2.4 Caucasian 11.6
Abbreviations: BCAMS, Beijing Child and Adolescent Metabolic Syndrome; BMI, body mass index; CARDIA, Coronary Artery Risk Development in Young Adults; CI, confidence interval; COPAT,
Childhood Obesity Prevalence and Treatment; GLACIER, Gene × Lifestyle Interactions and Complex Traits Involved in Elevated Disease Risk; MESA, Multi-Ethnic Study of Atherosclerosis; NR, not
reported; OR, odds ratio; PCSK1, proprotein convertase subtilisin/kexin type 1 gene; SNHAPC, Study on Nutrition and Health of Aging Population in China.
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Table 4. Characteristics of Included Studies and Their Constituent Cohorts (Change per Allele) in a Review and Meta-Analysis of the PCSK1 Single Nucleotide Polymorphisms rs6232 and
rs6234–rs6235 and Obesity-Related Quantitative Traits, December 2013
First Author,
Year (Reference No.) Cohort Ethnicity
Obesity-Related Trait and PCSK1 Single Nucleotide Polymorphism
Body Mass Indexa Waist Circumference, cm
rs6232 rs6234–rs6235 rs6232 rs6234–rs6235
β 95% CI β 95% CI β 95% CI β 95% CI
Kilpeläinen, 2009 (26) EPIC-Norfolk Caucasian 0.12 −0.04, 0.28 0.07 −0.01, 0.15 0.38 −0.05, 0.81 0.21 −0.01, 0.43
Meyre, 2009 (31) Childhood cohorts Caucasian −0.01 −0.12, 0.10 0.01 −0.03, 0.06
Adult cohorts Caucasian 0.08 −0.02, 0.10 0.03 −0.02, 0.07
Heni, 2010 (5) Tübingen family cohorts Caucasian −0.13 −1.29, 1.03 0.55 −0.08, 1.18 −0.74 −3.35, 1.87 0.95 −0.44, 2.34
Strawbridge, 2011 (4) Northern European cohorts Caucasian 0.02 0.01, 0.03
Gjesing, 2011 (9) Inter99 cohort Caucasian 0.20 −0.13, 0.53 0.06 −0.12, 0.25 0.47 −0.37, 1.31 0.34 −0.11, 0.79
Hester, 2012 (67) Cohort 1 African-American 0.41 −0.28, 1.10 0.06 −0.06, 0.18
Cohort 2 African-American 0.12 −0.39, 0.63 0.02 −0.10, 0.14
Cohort 3 African-American −0.47 −1.27, 0.33 −0.03 −0.19, 0.13
Cohort 4 African-American 0.08 −0.29, 0.45 −0.02 −0.12, 0.08
Cohort 5 African-American −0.45 −1.41, 0.51 −0.18 −0.40, 0.04
Cohort 6 African-American −0.01 −0.48, 0.46 0.11 −0.03, 0.25
Li, 2012 (68) Zhongshan Hospital Asian 0.33 0.08, 0.59 0.47 −0.01, 0.95
Choquet, 2013 (23) CARDIA I Caucasian 0.24 0.07, 0.41 0.05 −0.02, 0.12
CARDIA II African-American 0.13 0.01, 0.25
MESA I Caucasian 0.02 −0.09, 0.13 0.02 −0.05, 0.09
MESA II African-American −0.04 −0.13, 0.05
MESA III Hispanic −0.13 −0.39, 0.13 0.08 −0.02, 0.18
MESA IV Asian 0.02 −0.08, 0.12
Xi, 2013 (30) BCAMS Study Asian −0.21 −0.50, 0.08 −0.36 −1.06, 0.34
Renström, 2009 (45, 65) GLACIER Caucasian −0.03 −0.13, 0.06
Abbreviations: BCAMS, Beijing Child and Adolescent Metabolic Syndrome; CARDIA, Coronary Artery Risk Development in Young Adults; CI, confidence interval; EPIC, European
Prospective Investigation into Cancer and Nutrition; GLACIER, Gene × Lifestyle Interactions and Complex Traits Involved in Elevated Disease Risk; MESA, Multi-Ethnic Study of
Atherosclerosis; PCSK1, proprotein convertase subtilisin/kexin type 1 gene.
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Benzinou, 2008 (22) >98.5 100 >0.05 Y Y Child-adult Y Y Y Y Y 10
Kilpeläinen, 2009 (26) >96.4 98 >0.05 N Pc Y Y Y N Y Y 9
Meyre, 2009 (31) 97.70 99.7 >0.05 Y Y Y Y Y Y Y Y 11
Renström, 2009 (45, 65) >94 99 >0.01 N Y Y Y Y Y N Y 9
Qi, 2010 (36) >98.3 99.5 >0.05 Y P Y Y Y N Y Y 10
Sandholt, 2010 (10) >97.2 NR >0.05 Y P Y Y Y Y N Y 9
Heni, 2010 (5) >99 100 >0.1 Y P NA Y Y Y NA Y 11
Strawbridge, 2011 (4) >95 QCd QC N N NA Y Y Y NA Y 9
Gjesing, 2011 (9) >97 100 >0.7 Y P NA Y Y Y NA Y 11
Hester, 2012 (67) >95 >99 >0.001 N N NA N Y Y NA Y 8
Li, 2012 (68) >98.9 100 >0.05 Y Y Y Y Y Y Y Y 11
Rouskas, 2012 (25) >95 99 >0.01 Y Y Sex Y Y Y N Y 9
Villalobos-Comparán,
2012 (24)
>97 100 >0.05 Y Y Y Y Y N Y Y 10
Berndt, 2013 (32) QC QC >0.05 Y Y Y Y Y Y Y Y 11
Choquet, 2013 (23) MESA: 90
CARDIA: 99.6
NR >0.05 Y Y Y Y Y Y Y Y 10
Dušátková, 2013 (46) NR NR >0.05 Y Y Y Y Y N Y Y 8
Hsiao, 2014 (69) >99.2 100 >0.05 Y Y Y Y Y N Y Y 10
Xi, 2013 (30) >98 100 NR Y Y Y Y Y Y N Y 9
Körner, 2010 (70) >95 NR >0.05 Y Y Y Y Y N Y Y 9
Abbreviations: CARDIA, Coronary Artery Risk Development in Young Adults; HWE, Hardy-Weinberg equilibrium; MESA, Multi-Ethnic Study of Atherosclerosis; N, no; NA, not applicable; NR,
not reported; P, population; QC, quality control; PCSK1, proprotein convertase subtilisin/kexin type 1 gene; Y, yes.
a P values for HWE were extracted from the original papers.
b Total possible quality score: 11.
c Population-based cohort.





 at KU Leuven University Library on October 30, 2014 http://aje.oxfordjournals.org/ Downloaded from 























All cohorts 9 19 89,047 127,367 1.19 1.09, 1.29 40.6b 18 50 A B A
Subgroup Analyses
Cohort age
Childhood 4 5 2,669 4,031 1.43 1.19, 1.73 7.7 4 33 B A A
Adulthood 7 14 86,378 123,336 1.11 1.05, 1.18 23.1 13 12 A A B
P = 0.034c
Obesity grade
I (BMId 30–<35) 4 5 62,939 119,379 1.09 1.02, 1.16 2.8 4 9 A A A
II (BMI 35–<40) 3 3 16,505 106,807 1.16 0.91, 1.49 5.1 3 30 B A A
III (BMI ≥40) 4 5 6,320 77,322 1.21 0.84, 1.74 14.0b 4 78 B C C
P = 0.75c
Ethnicity
Caucasian 8 15 86,488 125,464 1.17 1.09, 1.27 29.1b 14 48 A B A
Hispanic 2 4 1,523 1,583 1.50 0.65, 3.48 1.0b 3 70 C C C
P = 0.56c
Quantitative trait (change per allele)
BMI 6 14 168,398 0.06e −0.00, 0.12 13.9 13 15 A B A
Waist circumference, cm 3 3 27,535 0.37e −0.00, 0.75 0.8 2 0 A B A
Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds ratio; PCSK1, proprotein convertase subtilisin/kexin type 1 gene.
a Venice criteria for the strength of cumulative epidemiologic evidence (44): Evidencewas considered strong when all 3 grades were “A,”moderatewhen grades included at least 1 “B” (but no
“C”), and weak if any grade was “C.”
b Significant heterogeneity (P < 0.05).
c P values were obtained from the Q test for heterogeneity.
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Table 7. Summary of Meta-Analysis Results and Rating of Cumulative Epidemiologic Evidence for an Association Between the Combined PCSK1 Single Nucleotide Polymorphisms






















All cohorts 14 28 93,232 136,743 1.09 1.04, 1.13 55.3b 27 65 A B A
Subgroup Analyses
Cohort age
Childhood 5 6 3,899 5,650 1.15 0.98, 1.36 23.2b 5 78 B C C
Adulthood 11 22 89,333 131,093 1.08 1.04, 1.11 31.5 21 35 A A A
P = 0.41c
Obesity grade
I (BMId 30–<35) 8 9 64,473 125,665 1.06 1.02, 1.09 8.8 8 5.6 A A A
II (BMI 35–<40) 4 6 18,606 112,638 1.07 1.03, 1.12 8.4 6 1.5 A A A
III (BMI ≥40) 5 6 6,948 82,589 1.12 1.00, 1.24 9.1 5 50 A B B
P = 0.57c
Ethnicity
Caucasian 9 18 89,200 130,509 1.10 1.04, 1.15 40.4b 17 72 A C A
Hispanic 2 4 1,523 1,583 1.08 0.95, 1.23 0.7 3 0 B A C
Asian 4 4 1,926 4,669 1.01 0.90, 1.13 5.3 3 24 B A C
P = 0.43c
Quantitative trait (change per allele)
BMI 10 21 184,728 0.02e 0.01, 0.03 28.2 20 1 A B B
Waist circumference, cm 5 5 31,484 0.24e 0.07, 0.41 5.0 4 0 A B B
Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds ratio; PCSK1, proprotein convertase subtilisin/kexin type 1 gene.
a Venice criteria for the strength of cumulative epidemiologic evidence (44): Evidence was considered strong when all 3 grades were “A,” moderate when grades included at least 1 “B”
(but no “C”), and weak if any grade was “C.”
b Significant heterogeneity (P < 0.05).
c P values were obtained from the Q test for heterogeneity.
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for adult cohorts, OR = 1.11, 95% CI: 1.05, 1.18; P =
0.03) but not for rs6234–rs6235 (childhood: OR = 1.15,
95% CI: 0.98, 1.36; adult: OR = 1.08, 95% CI: 1.04, 1.11;
P = 0.41) (Web Figure 2, Tables 6 and 7). The absence of a
significant association of rs6234–rs6235 with childhood obe-
sity and the absence of a difference in the associations with obe-
sity between childhood and adult cohorts might be due to the
large heterogeneity in the childhood subgroup ðI2 ¼ 78%),
whereas for rs6232, heterogeneity within subgroups was low
ðchildhood: I2 ¼ 33%; adult: I2 ¼ 12%).
To investigate whether the association also correlated with
age within the adult cohorts, we performed meta-regression
analysis for age. Neither of the associations with obesity
correlated with adult age (for rs6232, P = 0.5; for rs6234–
rs6235, P = 0.1).
Subgroup meta-analysis according to ethnicity
For rs6232, we analyzed the association with obesity for
Hispanic cohorts and Caucasian cohorts separately. We
found an association with obesity in the Caucasian popula-
tion (OR = 1.17, 95% CI: 1.09, 1.27) but not in the Hispanic
population (OR = 1.50, 95% CI: 0.65, 3.48) (Table 6). For
rs6234–rs6235, subgroup analyses showed that the combined
SNPs were not associated with obesity in the Asian popula-
tion (OR = 1.01, 95% CI: 0.90, 1.13; I2 = 24%) or the His-
panic population (OR = 1.08, 95% CI: 0.95, 1.23; I2 = 0%),
while they were associated with obesity in the Caucasian
population (OR = 1.10, 95% CI: 1.04, 1.15; I2 = 72%)
(Table 6). There were no significant differences in the asso-
ciation between the 3 ethnicity subgroups (P = 0.43). This
lack of association might be due to the low number of studies
carried out in Asian or Hispanic populations (n≤ 4), the rel-
atively small cohort sizes, or differences in cohort character-
istics as compared with the Caucasian cohorts. In both ethnic
groups, adult cohorts and childhood cohorts were present
with comparable age ranges. However, most Asian studies
contained only grade I obesity patients, in contrast to
Caucasian cohorts, in which all levels of obesity severity
were represented.
Meta-analyses of the association of PCSK1 SNPs with
quantitative traits
The PCSK1 SNPs investigated here have mostly been as-
sociated with severe obesity, but they have not been identified
in genome-wide association studies for BMI. Therefore, we
investigated the contribution of these SNPs to quantitative
traits (BMI and WC) (Web Figure 4). The association of
rs6232 with BMI was weak (β = 0.06, 95% CI: −0.00, 0.12).
Similarly, rs6234–rs6235 was only weakly associated with
increased BMI (β = 0.02, 95% CI: 0.01, 0.03), yet signifi-
cantly so. The heterogeneity within both meta-analyses was
low (I2 = 15% and I2 = 1% for rs6232 and rs6234–rs6235, re-
spectively). The meta-analysis of the limited number of stud-
ies reporting on WC showed that there was no significant
association of rs6232 with increased WC (β = 0.37, 95%
CI: −0.00, 0.75) (Web Figure 4). However, the SNP pair
rs6234–rs6235 was significantly associated with WC (β =
0.24, 95% CI: 0.07, 0.41). For rs6234–rs6235, the SNP
was more strongly associated with WC than with BMI. Be-
cause not all of the studies that reported on BMI also reported
on WC, we investigated whether this could be a subgroup ef-
fect. We analyzed the associations with BMI and WC within
the subgroup of cohort studies that reported on both WC and
BMI. The association of rs6234–rs6235 with WC remained
stronger than the association with BMI (BMI: β = 0.04, 95%
CI: −0.02, 0.11; WC: β = 0.24, 95% CI: 0.07, 0.41; P = 0.03).
Sensitivity analysis
The influence of studies prone to bias was investigated
using 2 meta-analyses. First, we conducted a sensitivity
analysis by excluding the studies that were appraised to be
most prone to bias and those that did not report on Hardy-
Weinberg equilibrium (Table 5; Web Table 1). Almost all re-
sults were robust to the sensitivity analysis for Dušátková
et al. (46) and Xi et al. (30). However, the sensitivity analysis
did yield a significant difference in the association of rs6234–
rs6235 with obesity between childhood cohorts and adult co-
horts (P = 0.005). In addition, heterogeneity (I2) within child-
hood cohorts was reduced to 30%, versus 78% before. The
significant difference between childhood and adult cohorts
in the association of rs6232 with obesity was reduced by re-
moving the study by Dušátková et al. (46) (P = 0.07). In a
second sensitivity analysis, the Swiss cohort described by
Meyre et al. (31) was replaced by the Swiss cohort described
by Benzinou et al. (22) (see above). The implications of the
sensitivity analysis for the Swiss adult cohort were discussed
above (Web Table 2).
Credibility of cumulative evidence
Using the Venice guidelines for rating cumulative epide-
miologic evidence, we assessed the credibility of the results
(44) (Table 6). For rs6232, only the subgroup analysis for
grade I obesity was considered to have produced strong epi-
demiologic evidence (“A”). The subgroup analysis for grade
III obesity received a “C” rating, because there was high het-
erogeneity and the results were not robust to sensitivity analy-
ses. The other analyses were rated as showing moderate
epidemiologic evidence (“B”). Quantitative-trait analyses re-
ceived a “B” rating for replication because of the low number
of studies, resulting in an overall “B” rating for cumulative
evidence. For rs6234–rs6235, subgroup analyses for adults,
grade I obesity, and grade II obesity were considered to pro-
vide strong epidemiologic evidence (“A”). Childhood and
ethnic subgroup analyses were considered to provide weak
epidemiologic evidence (“C”). Other analyses were rated as
providing moderate (“B”) epidemiologic evidence.
DISCUSSION
This meta-analysis combined data from 38 study cohorts
from 19 studies and comprised data on more than 200,000
participants. The cumulative epidemiologic evidence was
moderate for the general meta-analysis and strong for obesity
grade I subgroup analyses. The cumulative epidemiologic ev-
idence was particularly weak for Asian, obesity grade III, and
childhood subgroup analyses.











A significant association of the PCSK1 SNPs rs6232 and
rs6234–rs6235 with obesity was demonstrated. Furthermore,
we showed for the first time (to our knowledge) that the asso-
ciation ofPCSK1 rs6232with obesity is stronger in childhood
cohorts than in adult cohorts. After exclusion of 2 studies, we
observed a similar significant difference for rs6234–rs6235.
A nominal association with BMI was found for rs6234–
rs6235, but more importantly we showed for the first time
that rs6234–rs6235 contributes more to WC than to BMI.
Thesefindings suggest thatPCSK1 polymorphisms predispose
some people to central obesity, which leads to an increased risk
of cardiovascular disease and type 2 diabetes. In a large meta-
analysis, Heid et al. (50) showed that the genetic regulation of
body fat distribution is distinct from heritability of BMI or obe-
sity risk. Only aminority of genetic association studies useWC
as a measure of obesity, although evidence shows that WC and
waist:height ratio correlate better with diabetes, hypertension,
and cardiovascular disease (51).
The case-control study design enriches the sample for se-
vere cases and is therefore more sensitive to finding associa-
tions (48). This is demonstrated by the strong association of
PCSK1 SNPs with obesity versus the weak association with
BMI in this meta-analysis and in previous reports (27, 28,
31). In this meta-analysis, we tested whether the association
of the PCSK1 SNPs rs6232 and rs6234–rs6235 with obesity
correlated with obesity severity, but we found only limited
evidence for rs6234–rs6235.
The increased prevalence of childhood obesity is a hall-
mark of the current obesity epidemic. It is generally accepted
that obese children have a 50%–70% increased risk of being
obese in adulthood (52). Furthermore, heritability of BMI
varies with age. At birth, heritability is as low as 24%; it in-
creases throughout childhood to 55% at 1 year of age and up
to 70% or more during adolescence, while the genetic effect
on BMI in adults is estimated to be approximately 55%–85%
(53, 54). This increased inheritance during puberty could be
explained by the fact that persons with increased susceptibil-
ity might seek out obesogenic environments (55). Increased
inheritance has been observed in other traits and attributed to
gene-environment interaction (56–58). Gene-specific differ-
ences in inheritance patterns have been shown for variations
in the fat mass and obesity-associated gene (FTO) (55). How-
ever, to our knowledge, the question of whether gene expres-
sion alters with age has not been investigated for either FTO
or any other gene. In this study, subgroup analyses of child-
hood obesity versus adult obesity showed that rs6232 was
significantly more strongly associated with childhood obe-
sity. The same was true for rs6234–rs6235 within the context
of a sensitivity analysis.
Since the recognition of the obesity epidemic by the WHO
in 1997, the definition of BMI cutoff points for clinical obe-
sity in different populations has been much debated (1, 33,
34, 59). It is widely recognized that Asian and Hispanic pop-
ulations have increased risks of cardiovascular disease and
type 2 diabetes at lower BMIs than Caucasian populations.
This risk difference can be attributed to cultural, economic,
geographical, and genetic differences. This study assessed
the association of PCSK1 SNPs with obesity in different pop-
ulations. PCSK1 rs6234–rs6235 was shown to be associated
with obesity in Caucasians but not in Asians or Hispanics.
Ourmeta-analysis also included cohorts ofAfrican-American
descent, but there were too few cohorts for us to perform any
analysis. The lack of associations was largely due to the lack of
a sufficient number and size of studies for these ethnic groups.
PC1/3, the gene product of PCSK1, is expressed in neuronal
and endocrine cells, in which it cleaves and hence activates
a variety of prohormones and proneuropeptides. Besides their
implications for feeding behavior and thermogenesis, the
PCSK1 SNPs rs6232 and rs6234–rs6235 have also been as-
sociated with differences in glucose homeostasis, proinsulin
disorders, fat oxidation, and postabsorptive resting energy
expenditure (4–10). Since 1997, several patients with con-
genital PCSK1 deficiency have been identified (2, 11–16).
Recently, patients who are heterozygous for nonsynonymous
mutations in PCSK1 have been identified, which shows that
PCSK1 mutations can cause obesity in a dominant manner
(60, 61). Remarkably, several of these variants have been
found to have only mild functional effects on PC1/3 activity
in vitro. It remains unclear how PCSK1 SNPs contribute to
obesity and to what extent environmental factors might be
important. The use of mouse models might be instrumental
in addressing these questions. To date, 2 mouse models for
PC1/3 deficiencyare available (62, 63).ThePcsk1-nullmouse
displays a growth retardation phenotype, due to impaired
processing of pro–growth-hormone-releasing hormone (62).
However, the Pcsk1-null micewere not reported to be obese. In
another mouse model, mice harboring the Pcsk1-p.Asn222Asp
mutation do become obese (63). Interestingly, the amino acid
change of asparagine at position 222 is the neighboring
amino acid of PCSK1-p.Asn221Asp (encoded by rs6232)
in human PC1/3. Recently, it has been shown in vitro that
mouse PC1/3-p.Asn222Asp is defectively transported from
theendoplasmic reticulumcompartment (64).Researchaimed
at obesity pathogenesis in this model might yield interesting
therapeutic avenues for treatment of PCSK1-related human
obesity.
In addition to the SNPs investigated in this study, 2 other
SNPs in close proximity to PCSK1 have been identified as
contributing to obesity phenotypes. The SNP rs2570467 has
been found to be mildly associated with WC in populations
of African ancestry (29), and rs261967 has been identified as
being associated with BMI at the genome-wide level in East
Asians (21). Interestingly, both SNPs are located in a tran-
script antisense to PCSK1 exons and might regulate PCSK1
expression.
This study was limited by the assumption that the genetic
risk of PCSK1 SNPs is additive and by the fact that no correc-
tions were made for multiple testing. Although we feel it was
justified, our choice of random-effects models to calculate
summary effects for the association was conservative and re-
duced the statistical power of the tests. Thiswas exemplified by
the nonsignificant associations for obesity grade II and grade
III cohorts, whereas Berndt et al. (32) found significant asso-
ciations for all obesity classes in their meta-analysis.
This study had good statistical power (>97%) tofind the over-
all association, but the study was limited by the low power in
certain subgroups, such as the Asian, childhood (6 cohorts),
and obesity grades II and III subgroups (10%–40%). Since
the effect sizes for the association of PCSK1 SNPs with
obesity were relatively small (OR = 1.10), it is important











to conduct more studies for these subgroups. To date, most of
the available genetic information pertains to the Caucasian
population, but there is also increasingly information avail-
able for the Asian population. Genetic association studies
in Hispanic and (particularly) African populations are scarce.
We recommend that more good-quality studies be conducted
in these populations.
In conclusion, the current meta-analysis showed a mild but
significant contribution of the PCSK1 SNPs rs6232 and
rs6234–rs6235 to the genetic predisposition to obesity in an
age- and ethnicity-dependent fashion. In addition, we dem-
onstrated that rs6234–rs6235 is more strongly associated
with WC than with BMI, which sheds new light on PCSK1-
related obesity.
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